home
Home
info
About Us
toggle_off
Company Profile
groups
Boards & Staffs
workspace_premium
Memberships & Partners
school
Academy of Journalism
person_add
Careers
link
Blog(EN)
email
Contact Us
menu_book
Journals
list_alt
Our Journals
lightbulb
Instruction for Authors
bookmark
Brieflands Policies
handshake
Publish My Research
play_circle
Journal Management System
credit_card
Article Processing Charges
zoom_in
Open Peer Review
image
Publishing Services
view_list
Books
menu_book
Publish My Book
Brieflands
journals
IJ Pharmaceutical Research
Articles
Insulin and TLR4 Inhibitor Improve Motor Impairments in a Rat Model of Parkinson’s Disease
Scopus by Title (Ref)
IJ Pharmaceutical Research
home
Home
menu_book
Archives
play_arrow
Current Issue
format_list_bulleted
All Issues
format_indent_increase
In Press
check_box
Accepted Manuscripts
search
Search
qr_code
Instructions
info
About Journal
bookmark
Journal Information
groups
Editors & Boards
share
Indexing and Listing Sources
waterfall_chart
Journal Metrics
zoom_in
Open Peer Review (OPR)
balance
Publication Ethics and Malpractice Statement
assignment_ind
Reviewer and AE Registration Form
email
Support
phone
Contact Us
menu
APC
Authors Guide
Submit Manuscript
Scopus by Title (Ref)
1. Taking its TOLL: the role of toll-like receptor 4 in human health and disease, and its potential as a therapeutic target
- Crammond P. , et al.
2. Potentials of cepharanthine and tomatidine as novel LpxC and TLR4 inhibitors to mitigate gut-mediated inflammation in Parkinson’s disease: a high-throughput investigation through molecular docking and dynamic simulation
- Roy R. , et al.